Wall Street Analysts' Sentiment on UnitedHealth Group Incorporated (UNH) Stock

UnitedHealth Group (UNH) has underperformed the broader market over the past year, declining 46.5% compared to the S&P 500 Index's 12.7% gain. The stock's struggles stem from Medicare funding cuts and higher healthcare costs, but the company expects margin recovery in 2026. Analysts are cautiously optimistic, with a consensus "Moderate Buy" rating based on 15 "Strong Buy" ratings, two "Moderate Buys," eight "Holds," and one "Strong Sell."